HUP0203311A2 - New pharmaceutical compositions of prolonged effect - Google Patents

New pharmaceutical compositions of prolonged effect

Info

Publication number
HUP0203311A2
HUP0203311A2 HU0203311A HUP0203311A HUP0203311A2 HU P0203311 A2 HUP0203311 A2 HU P0203311A2 HU 0203311 A HU0203311 A HU 0203311A HU P0203311 A HUP0203311 A HU P0203311A HU P0203311 A2 HUP0203311 A2 HU P0203311A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
new pharmaceutical
prolonged effect
prolonged
effect
Prior art date
Application number
HU0203311A
Other languages
Hungarian (hu)
Inventor
Ian Stuart Muir
Angela Catherine Potts
Michael John Rowley
Edward Eric Sims
Christopher Steven Wilson
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of HUP0203311A2 publication Critical patent/HUP0203311A2/en
Publication of HUP0203311A3 publication Critical patent/HUP0203311A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
HU0203311A 1999-10-04 2000-09-29 New pharmaceutical compositions of prolonged effect HUP0203311A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923436.1A GB9923436D0 (en) 1999-10-04 1999-10-04 Pharmaceutical compositions
PCT/EP2000/009576 WO2001024777A1 (en) 1999-10-04 2000-09-29 Coated solid dosage forms

Publications (2)

Publication Number Publication Date
HUP0203311A2 true HUP0203311A2 (en) 2004-05-28
HUP0203311A3 HUP0203311A3 (en) 2004-06-28

Family

ID=10862090

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203311A HUP0203311A3 (en) 1999-10-04 2000-09-29 New pharmaceutical compositions of prolonged effect

Country Status (13)

Country Link
EP (1) EP1217992A1 (en)
JP (1) JP2003510346A (en)
CN (1) CN1402630A (en)
AR (1) AR025938A1 (en)
AU (1) AU783911B2 (en)
CA (1) CA2383306A1 (en)
GB (1) GB9923436D0 (en)
HU (1) HUP0203311A3 (en)
MX (1) MXPA02003440A (en)
NZ (1) NZ518033A (en)
TW (1) TWI233363B (en)
WO (1) WO2001024777A1 (en)
ZA (1) ZA200203486B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR100434904B1 (en) * 2002-05-30 2004-06-11 주식회사 대웅 Enteric formulations containing stabilized lansoprazole
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
ITMI20030616A1 (en) * 2003-03-28 2004-09-29 Acme Drugs S R L METHOD FOR THE PREPARATION OF DRUGS, FOODS, FOOD SUPPLEMENTS, GASTROPROTECTS AND / OR CONTROLLED RELEASE, DIET PRODUCTS, PREMIXES FOR MANGIM, ADDITIVES FOR ZOOTECHNICAL FEEDING CONTAINING SENSITIVE ACTIVE INGREDIENTS
EP1660052A2 (en) * 2003-09-03 2006-05-31 Agi Therapeutics Limited Proton pump inhibitor formulations, and methods of preparing and using such formulations
WO2006009602A2 (en) 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
AR051654A1 (en) * 2004-11-04 2007-01-31 Astrazeneca Ab NEW FORMULATIONS OF MODIFIED RELEASE PELLETS FOR PROTON PUMP INHIBITORS
AR052225A1 (en) * 2004-11-04 2007-03-07 Astrazeneca Ab FORMULATIONS OF MODIFIED RELEASE TABLETS FOR INHIBITORS OF THE PUMP OF PROTONS
ATE485814T1 (en) * 2005-08-19 2010-11-15 Verla Pharm MAGNESIUM DELAYED RELEASE MICRO TABLETS
US20070298105A1 (en) * 2006-06-27 2007-12-27 Hwang Stephen S Methods of treating conditions by sustained release administration of benzimidazole derivatives
JP2012502015A (en) 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ Method for delivering a pharmaceutical composition to a patient in need thereof
WO2010096814A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled-release compositions comprising a proton pump inhibitor
EA201290026A1 (en) 2009-06-25 2012-07-30 Астразенека Аб A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA
SI2651398T1 (en) 2010-12-16 2018-04-30 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
AU2012241894B2 (en) 2011-04-12 2015-12-03 Novo Nordisk A/S Double-acylated GLP-1 derivatives
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
ES2690553T3 (en) 2012-03-22 2018-11-21 Novo Nordisk A/S GLP-1 peptide compositions and preparation of these
DK2827845T3 (en) 2012-03-22 2019-04-01 Novo Nordisk As COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF
EP3542790B1 (en) 2012-03-22 2023-09-13 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
US9993430B2 (en) 2012-06-20 2018-06-12 Novo Nordisk A/S Tablet formulation comprising semaglutide and a delivery agent
CN102846571A (en) * 2012-09-29 2013-01-02 南京正科制药有限公司 Esomeprazole magnesium micro-tablet
WO2019149880A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3456211B2 (en) * 1991-09-27 2003-10-14 藤沢薬品工業株式会社 Long-acting formulation
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
EP1017370B1 (en) * 1997-09-11 2003-10-29 Nycomed Danmark ApS MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
SE9704870D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
JP2000128779A (en) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc Controlled release medicine type preparation

Also Published As

Publication number Publication date
WO2001024777A1 (en) 2001-04-12
EP1217992A1 (en) 2002-07-03
TWI233363B (en) 2005-06-01
AU783911B2 (en) 2005-12-22
JP2003510346A (en) 2003-03-18
AU1020601A (en) 2001-05-10
GB9923436D0 (en) 1999-12-08
HUP0203311A3 (en) 2004-06-28
AR025938A1 (en) 2002-12-18
CA2383306A1 (en) 2001-04-12
MXPA02003440A (en) 2004-09-10
ZA200203486B (en) 2003-08-04
CN1402630A (en) 2003-03-12
NZ518033A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
PL351387A1 (en) Pharmaceutical composition
HK1044476A1 (en) Medicinal compositions
IL148864A (en) Pharmaceutical compositions containing nimesulide
AU6219601A (en) Pharmaceutical compositions
HUP0201068A3 (en) Pharmaceutical compositions of erythropoietin
EP1166786A4 (en) Medicinal compositions
AU8576801A (en) Pharmaceutical compositions
GB9904163D0 (en) Pharmaceutical compositions
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
AU1390002A (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
GB9904911D0 (en) Pharmaceutical compositions
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
IL149470A0 (en) Pharmaceutical compositions containing carboxamidoadenosine derivatives
GB9902651D0 (en) Pharmaceutical compositions
GB9902594D0 (en) Pharmaceutical compositions
GB9920652D0 (en) Pharmaceutical compositions
GB9902591D0 (en) Pharmaceutical compositions
IL132705A0 (en) Compounds and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees